Male patients with hidradenitis suppurativa (HS) perceive better physician communication with respect to demonstrating ...

A new study published in the Journal of American Medical Association showed that the prevalence of physical and mental comorbidities was greater in children with hidradenitis ...

A new study published in the journal of PloS One found a significant link between smoking and a heightened risk of ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

Dr. Vlada Groysman of Cahaba Dermatology is the ONLY vulvar dermatologist in the Southeast. Get to know this trailblazing ...

Novartis’ IL-17 inhibitor Cosentyx has become the first new biological therapy for the painful skin condition hidradenitis suppurativa (HS) in nearly a decade, following its approval by the ...

AbbVie is testing its oral drug upadacitinib in a Phase 3 trial for patients with hidradenitis suppurativa (HS) who failed ...

The latest start-up to emerge from the Roivant stable is named Priovant Therapeutics, and has been formed to develop a JAK1/TYK2 inhibitor originated by Pfizer as a treatment for autoimmune ...

Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...

Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.